Literature DB >> 8459005

Normative ground reaction force data for able-bodied and below-knee-amputee children during walking.

J R Engsberg1, A G Lee, K G Tedford, J A Harder.   

Abstract

We determined normative ground reaction force data for able-bodied (AB) and below-knee-amputee (BKA) children during walking. Twenty-two BKA and 225 able-bodied children walked over two adjacent force platforms. Average normalized force-time curves were determined for legs of the children for subjective comparisons, and discrete variables were determined for statistical comparisons. No significant differences existed between (a) right and left legs, (b) gender, and (c) age for the AB children. BKA children had an asymmetrical gait pattern with a dominant role of the nonprosthetic limb. This dominant role was related to a greater rate of loading, magnitude of loading, impulse, and time of loading as compared with prosthetic limbs and with the limbs of AB children.

Entities:  

Mesh:

Year:  1993        PMID: 8459005

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  3 in total

1.  Dynamic stability of superior vs. inferior body segments in individuals with transtibial amputation walking in destabilizing environments.

Authors:  Rainer Beurskens; Jason M Wilken; Jonathan B Dingwell
Journal:  J Biomech       Date:  2014-07-10       Impact factor: 2.712

2.  Gait asymmetry of transfemoral amputees using mechanical and microprocessor-controlled prosthetic knees.

Authors:  Kenton R Kaufman; Serena Frittoli; Carlo A Frigo
Journal:  Clin Biomech (Bristol, Avon)       Date:  2012-01-04       Impact factor: 2.063

3.  Kinetic Gait Parameters in Unilateral Lower Limb Amputations and Normal Gait in Able-Bodied: Reference Values for Clinical Application.

Authors:  Karin Schmid-Zalaudek; Theresa Fischer; Zoltán Száva; Helmut Karl Lackner; Ursula Kropiunig; Christian Bittner; Karl Höcker; Günther Winkler; Gerfried Peternell
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.